BRCTF
Price
$16.60
Change
+$0.07 (+0.42%)
Updated
Apr 11 closing price
Capitalization
1.44B
RLAY
Price
$2.42
Change
+$0.20 (+9.01%)
Updated
Apr 11 closing price
Capitalization
410.24M
19 days until earnings call
Ad is loading...

BRCTF vs RLAY

Header iconBRCTF vs RLAY Comparison
Open Charts BRCTF vs RLAYBanner chart's image
BIOARCTIC AB
Price$16.60
Change+$0.07 (+0.42%)
Volume$381
Capitalization1.44B
Relay Therapeutics
Price$2.42
Change+$0.20 (+9.01%)
Volume$2.32M
Capitalization410.24M
BRCTF vs RLAY Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRCTF vs. RLAY commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRCTF is a Hold and RLAY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (BRCTF: $16.60 vs. RLAY: $2.42)
Brand notoriety: BRCTF and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRCTF: 80% vs. RLAY: 96%
Market capitalization -- BRCTF: $1.44B vs. RLAY: $410.24M
BRCTF [@Biotechnology] is valued at $1.44B. RLAY’s [@Biotechnology] market capitalization is $410.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRCTF’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • BRCTF’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both BRCTF and RLAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 3 TA indicator(s) are bullish.

  • RLAY’s TA Score: 3 bullish, 4 bearish.

Price Growth

BRCTF (@Biotechnology) experienced а -8.29% price change this week, while RLAY (@Biotechnology) price change was +21.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRCTF($1.44B) has a higher market cap than RLAY($410M). BRCTF YTD gains are higher at: -9.295 vs. RLAY (-41.262). BRCTF has higher annual earnings (EBITDA): -187.67M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. BRCTF (513M). RLAY has less debt than BRCTF: RLAY (48.5M) vs BRCTF (54.2M). BRCTF has higher revenues than RLAY: BRCTF (257M) vs RLAY (10M).
BRCTFRLAYBRCTF / RLAY
Capitalization1.44B410M351%
EBITDA-187.67M-380.21M49%
Gain YTD-9.295-41.26223%
P/E Ratio91.58N/A-
Revenue257M10M2,570%
Total Cash513M781M66%
Total Debt54.2M48.5M112%
TECHNICAL ANALYSIS
Technical Analysis
RLAY
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIOPX39.70N/A
N/A
Baron Opportunity Retail
CREEX8.99N/A
N/A
Columbia Real Estate Equity Inst
RSPMX24.45N/A
N/A
Victory RS Partners Member
JSMGX23.33N/A
N/A
Janus Henderson Triton I
ALPBX11.36N/A
N/A
ALPS/Smith Balanced Opportunity I

BRCTF and

Correlation & Price change

A.I.dvisor tells us that BRCTF and CGTX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BRCTF and CGTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRCTF
1D Price
Change %
BRCTF100%
+0.42%
CGTX - BRCTF
28%
Poorly correlated
+10.49%
RLAY - BRCTF
25%
Poorly correlated
+9.01%
SNDX - BRCTF
22%
Poorly correlated
+6.08%
PHGUF - BRCTF
22%
Poorly correlated
N/A
GRI - BRCTF
21%
Poorly correlated
+9.92%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+9.01%
XNCR - RLAY
50%
Loosely correlated
+7.83%
RXRX - RLAY
46%
Loosely correlated
+27.72%
BCYC - RLAY
45%
Loosely correlated
+2.60%
BDTX - RLAY
44%
Loosely correlated
-2.11%
VCYT - RLAY
44%
Loosely correlated
+5.12%
More